Search
Mainz Biomed NV
MYNZAdd to Watchlist
0.844USD
0.0000.00%
Market hours （ET）Quotes delayed by 15 min
35.06MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-03-11The current earnings forecast score of Mainz Biomed NV is 8.00, ranking 27 out of 75 in the Healthcare Providers & Services industry. The average price target is 14.00, with a high of 14.00 and a low of 14.00.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
14.000
Target Price
+1650.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Mainz Biomed NV
MYNZ
1
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
23
Tenet Healthcare Corp
THC
23
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Mainz Biomed NV's price target?
Analysts forecast that Mainz Biomed NV's price target is USD 14.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 14.00.
What is the analyst rating for Mainz Biomed NV?
Based on the ratings of Mainz Biomed NV's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.